GLP-1, SGLT2 medications may lower stroke survivor's risk of future heart attack, stroke
November 11, 2024
November 11, 2024
DALLAS, Texas, Nov. 11 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death compared to peers who were not prescribed the medications during a three-year follow up period.
The analysis used health da . . .
Research Highlights:
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death compared to peers who were not prescribed the medications during a three-year follow up period.
The analysis used health da . . .